Although it is evident that JAK2 acts as an oncogene in both myeloproliferative disorders and some solid tumors [25], [26], [27], no direct involvement of JAK2 in cancer migration, invasion or metastasis has been reported. This evidence concerns the gene JAK2 and cancer.